96 related articles for article (PubMed ID: 18049891)
1. NBS1 variant I171V and breast cancer risk.
Bogdanova N; Schürmann P; Waltes R; Feshchenko S; Zalutsky IV; Bremer M; Dörk T
Breast Cancer Res Treat; 2008 Nov; 112(1):75-9. PubMed ID: 18049891
[TBL] [Abstract][Full Text] [Related]
2. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene.
Ziólkowska I; Mosor M; Wierzbicka M; Rydzanicz M; Pernak-Schwarz M; Nowak J
Cancer Sci; 2007 Nov; 98(11):1701-5. PubMed ID: 17894553
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.
Nowak J; Mosor M; Ziółkowska I; Wierzbicka M; Pernak-Schwarz M; Przyborska M; Roznowski K; Pławski A; Słomski R; Januszkiewicz D
Eur J Cancer; 2008 Mar; 44(4):627-30. PubMed ID: 18280732
[TBL] [Abstract][Full Text] [Related]
5. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
[TBL] [Abstract][Full Text] [Related]
6. Is the NBN gene mutation I171V a potential risk factor for malignant solid tumors in children?
Nowak J; Mosor M; Nowicka K; Rembowska J; Januszkiewicz D
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e248-9. PubMed ID: 21436738
[TBL] [Abstract][Full Text] [Related]
7. Nijmegen Breakage Syndrome mutations and risk of breast cancer.
Bogdanova N; Feshchenko S; Schürmann P; Waltes R; Wieland B; Hillemanns P; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Varon R; Dörk T
Int J Cancer; 2008 Feb; 122(4):802-6. PubMed ID: 17957789
[TBL] [Abstract][Full Text] [Related]
8. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
10. NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis.
Wang Z; Cui D; Lu W
Breast Cancer Res Treat; 2010 Sep; 123(2):557-61. PubMed ID: 20143155
[TBL] [Abstract][Full Text] [Related]
11. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation.
Kim H; Cho DY; Choi DH; Jung GH; Shin I; Park W; Huh SJ; Kim SW; Park SK; Lee JW; Nam SJ; Lee JE; Gil WH; Kim SW
Fam Cancer; 2015 Sep; 14(3):365-71. PubMed ID: 25712764
[TBL] [Abstract][Full Text] [Related]
13. Functional variants in NBS1 and cancer risk: evidence from a meta-analysis of 60 publications with 111 individual studies.
Gao P; Ma N; Li M; Tian QB; Liu DW
Mutagenesis; 2013 Nov; 28(6):683-97. PubMed ID: 24113799
[TBL] [Abstract][Full Text] [Related]
14. Penetrance analysis of the PALB2 c.1592delT founder mutation.
Erkko H; Dowty JG; Nikkilä J; Syrjäkoski K; Mannermaa A; Pylkäs K; Southey MC; Holli K; Kallioniemi A; Jukkola-Vuorinen A; Kataja V; Kosma VM; Xia B; Livingston DM; Winqvist R; Hopper JL
Clin Cancer Res; 2008 Jul; 14(14):4667-71. PubMed ID: 18628482
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic analysis of NBS1 in German melanoma patients.
Meyer P; Stapelmann H; Frank B; Varon R; Burwinkel B; Schmitt C; Boettger MB; Klaes R; Sperling K; Hemminki K; Kammerer S
Melanoma Res; 2007 Apr; 17(2):109-16. PubMed ID: 17496786
[TBL] [Abstract][Full Text] [Related]
16. The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk.
Frank B; Hemminki K; Wirtenberger M; Bermejo JL; Bugert P; Klaes R; Schmutzler RK; Wappenschmidt B; Bartram CR; Burwinkel B
Carcinogenesis; 2005 Mar; 26(3):643-7. PubMed ID: 15550452
[TBL] [Abstract][Full Text] [Related]
17. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
[TBL] [Abstract][Full Text] [Related]
18. Association of ionizing radiation-induced foci of NBS1 with chromosomal instability and breast cancer susceptibility.
Someya M; Sakata K; Tauchi H; Matsumoto Y; Nakamura A; Komatsu K; Hareyama M
Radiat Res; 2006 Oct; 166(4):575-82. PubMed ID: 17007554
[TBL] [Abstract][Full Text] [Related]
19. Association of two mutations in the CHEK2 gene with breast cancer.
Bogdanova N; Enssen-Dubrowinskaja N; Feshchenko S; Lazjuk GI; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Dörk T
Int J Cancer; 2005 Aug; 116(2):263-6. PubMed ID: 15810020
[TBL] [Abstract][Full Text] [Related]
20. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
Watanabe T; Nobusawa S; Lu S; Huang J; Mittelbronn M; Ohgaki H
J Neuropathol Exp Neurol; 2009 Feb; 68(2):210-5. PubMed ID: 19151620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
